These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 27592529)
1. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base. Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529 [TBL] [Abstract][Full Text] [Related]
2. Sociodemographic and survival disparities for histologic variants of bladder cancer. Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972 [TBL] [Abstract][Full Text] [Related]
3. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811 [TBL] [Abstract][Full Text] [Related]
4. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival. Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base. Royce TJ; Lin CC; Gray PJ; Shipley WU; Jemal A; Efstathiou JA Urol Oncol; 2018 Feb; 36(2):78.e1-78.e12. PubMed ID: 29162314 [TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation. Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593 [TBL] [Abstract][Full Text] [Related]
7. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy. Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489 [TBL] [Abstract][Full Text] [Related]
8. Prognosis of early stage small cell bladder cancer is not always dismal. Lim JH; Sundar S ESMO Open; 2019; 4(6):e000559. PubMed ID: 31798978 [TBL] [Abstract][Full Text] [Related]
9. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. Montie JE J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778 [No Abstract] [Full Text] [Related]
10. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779 [TBL] [Abstract][Full Text] [Related]
11. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101 [TBL] [Abstract][Full Text] [Related]
12. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. Mitra AP; Skinner EC; Miranda G; Daneshmand S BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881 [TBL] [Abstract][Full Text] [Related]
13. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer. Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
16. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135 [TBL] [Abstract][Full Text] [Related]
17. Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. Meijer RP; Meinhardt W; van der Poel HG; van Rhijn BW; Kerst JM; Pos FJ; Horenblas S; Bex A Int J Urol; 2013 Aug; 20(8):778-84. PubMed ID: 23231456 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155 [TBL] [Abstract][Full Text] [Related]
19. Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns. Patel SG; Stimson CJ; Zaid HB; Resnick MJ; Cookson MS; Barocas DA; Chang SS J Urol; 2014 Feb; 191(2):329-34. PubMed ID: 24036236 [TBL] [Abstract][Full Text] [Related]
20. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]